InsiderTrades.com logo

AKBA Insider Trading

Insider Ownership Percentage: 3.00%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $848,057.30

Akebia Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Akebia Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Akebia Therapeutics Share Price & Price History

Current Price: $1.59
Price Change: ▲ Price Increase of +0.02 (1.27%)
As of 12/4/2025 05:00 PM ET

This chart shows the closing price history over time for AKBA up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Akebia Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/30/2025Erik OstrowskiCFOSell41,314$3.67$151,622.38503,586View SEC Filing Icon  
6/9/2025Richard C MalabreCAOSell15,000$4.01$60,150.00266,914View SEC Filing Icon  
6/4/2025Richard C MalabreCAOSell13,334$3.53$47,069.02266,914View SEC Filing Icon  
2/3/2025John P. ButlerCEOSell144,250$2.10$302,925.002,604,330View SEC Filing Icon  
2/3/2025Nicholas GrundInsiderSell55,621$2.10$116,804.10442,579View SEC Filing Icon  
2/3/2025Richard C MalabreCAOSell30,202$2.10$63,424.20280,248View SEC Filing Icon  
2/3/2025Steven Keith BurkeSVPSell50,506$2.10$106,062.60816,234View SEC Filing Icon  
2/29/2024John P. ButlerCEOSell46,570$1.58$73,580.602,044,580View SEC Filing Icon  
2/29/2024Michel DahanCOOSell8,661$1.58$13,684.38706,932View SEC Filing Icon  
2/29/2024Nicole R HadasSVPSell5,974$1.58$9,438.92663,259View SEC Filing Icon  
2/27/2024John P. ButlerCEOSell37,733$1.52$57,354.162,091,150View SEC Filing Icon  
2/27/2024Michel DahanCOOSell10,744$1.52$16,330.88715,593View SEC Filing Icon  
2/27/2024Nicole R HadasSVPSell7,411$1.52$11,264.72669,233View SEC Filing Icon  
2/1/2024John P. ButlerCEOSell46,489$1.68$78,101.522,128,883View SEC Filing Icon  
2/1/2024Steven Keith BurkeSVPSell24,311$1.68$40,842.48711,376View SEC Filing Icon  
5/25/2023Michel DahanCOOSell95,478$1.22$116,483.16574,037View SEC Filing Icon  
5/25/2023Nicole R HadasSVPSell63,186$1.22$77,086.92524,344View SEC Filing Icon  
5/16/2023Steven Keith BurkeSVPSell63,567$1.07$68,016.69530,487View SEC Filing Icon  
3/1/2023David A. SpellmanCFOSell7,210$0.88$6,344.80510,050View SEC Filing Icon  
3/1/2023John P. ButlerCEOSell91,868$0.88$80,843.841,568,872View SEC Filing Icon  
3/1/2023Michel DahanCOOSell20,412$0.88$17,962.56269,515View SEC Filing Icon  
3/1/2023Nicole R HadasSVPSell13,034$0.88$11,469.92287,530View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Akebia Therapeutics (NASDAQ:AKBA)

33.92% of Akebia Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at AKBA by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Akebia Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/21/2025CIBC Bancorp USA Inc.26,650$73K0.0%N/A0.010%Search for SEC Filing on Google Icon
11/17/2025Jacobs Levy Equity Management Inc.662,530$1.81M0.0%-45.0%0.250%Search for SEC Filing on Google Icon
11/17/2025CANADA LIFE ASSURANCE Co29,089$79K0.0%N/A0.011%Search for SEC Filing on Google Icon
11/17/2025Voleon Capital Management LP211,766$0.58M0.0%N/A0.080%Search for SEC Filing on Google Icon
11/17/2025Sherbrooke Park Advisers LLC28,387$77K0.0%N/A0.011%Search for SEC Filing on Google Icon
11/17/2025Polymer Capital Management US LLC18,232$50K0.0%+49.5%0.007%Search for SEC Filing on Google Icon
11/17/2025Qube Research & Technologies Ltd3,206,184$8.75M0.0%+87.0%1.208%Search for SEC Filing on Google Icon
11/17/2025Prelude Capital Management LLC32,840$90K0.0%-21.3%0.012%Search for SEC Filing on Google Icon
11/17/2025Millennium Management LLC2,857,237$7.80M0.0%+32.1%1.077%Search for SEC Filing on Google Icon
11/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.139,736$0.38M0.0%-6.5%0.053%Search for SEC Filing on Google Icon
11/17/2025Focus Partners Wealth30,591$87K0.0%+130.6%0.012%Search for SEC Filing on Google Icon
11/17/2025Brevan Howard Capital Management LP78,121$0.21M0.0%+355.6%0.029%Search for SEC Filing on Google Icon
11/17/2025Bank of America Corp DE1,788,500$4.88M0.0%+61.1%0.674%Search for SEC Filing on Google Icon
11/17/2025Aquatic Capital Management LLC506,909$1.38M0.0%+942.3%0.191%Search for SEC Filing on Google Icon
11/17/2025Ameriprise Financial Inc.10,576$29K0.0%-94.0%0.004%Search for SEC Filing on Google Icon
11/14/2025Lazard Asset Management LLC25,174$69K0.0%-78.4%0.009%Search for SEC Filing on Google Icon
11/14/2025Raymond James Financial Inc.69,785$0.19M0.0%+17.3%0.026%Search for SEC Filing on Google Icon
11/14/2025Freestone Grove Partners LP202,122$0.55M0.0%N/A0.076%Search for SEC Filing on Google Icon
11/14/2025Man Group plc124,426$0.34M0.0%+198.3%0.047%Search for SEC Filing on Google Icon
11/14/2025California State Teachers Retirement System247,700$0.68M0.0%+1,543.3%0.093%Search for SEC Filing on Google Icon
11/14/2025Zurcher Kantonalbank Zurich Cantonalbank 55,473$0.15M0.0%N/A0.021%Search for SEC Filing on Google Icon
11/14/2025UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC326,959$0.89M0.0%+1,097.4%0.123%Search for SEC Filing on Google Icon
11/14/2025Squarepoint Ops LLC778,529$2.13M0.0%+383.0%0.294%Search for SEC Filing on Google Icon
11/13/2025Invesco Ltd.2,400,757$6.55M0.0%+528.1%0.905%Search for SEC Filing on Google Icon
11/13/2025Sei Investments Co.56,500$0.15M0.0%-70.5%0.021%Search for SEC Filing on Google Icon
11/13/2025UBS Group AG3,646,233$9.95M0.0%+470.2%1.375%Search for SEC Filing on Google Icon
11/13/2025BNP Paribas Financial Markets858,541$2.34M0.0%+64.9%0.324%Search for SEC Filing on Google Icon
11/13/2025Mackenzie Financial Corp265,280$0.72M0.0%+6.7%0.100%Search for SEC Filing on Google Icon
11/13/2025Franklin Resources Inc.2,680,188$7.32M0.0%+0.5%1.011%Search for SEC Filing on Google Icon
11/13/2025Legal & General Group Plc245,251$0.67M0.0%+953.5%0.092%Search for SEC Filing on Google Icon
11/13/2025Russell Investments Group Ltd.132,436$0.36M0.0%+34.0%0.050%Search for SEC Filing on Google Icon
11/12/2025Barclays PLC1,180,233$3.22M0.0%+19.9%0.445%Search for SEC Filing on Google Icon
11/12/2025Dimensional Fund Advisors LP1,766,691$4.82M0.0%+100.3%0.666%Search for SEC Filing on Google Icon
11/12/2025Victory Capital Management Inc.286,385$0.78M0.0%+853.6%0.108%Search for SEC Filing on Google Icon
11/12/2025Rafferty Asset Management LLC481,869$1.32M0.0%+89.7%0.182%Search for SEC Filing on Google Icon
11/12/2025Intech Investment Management LLC101,969$0.28M0.0%-28.7%0.038%Search for SEC Filing on Google Icon
11/12/2025Empirical Asset Management LLC20,000$55K0.0%N/A0.008%Search for SEC Filing on Google Icon
11/10/2025Citigroup Inc.1,916,692$5.23M0.0%+1,324.7%0.723%Search for SEC Filing on Google Icon
11/7/2025GSA Capital Partners LLP182,443$0.50M0.0%N/A0.069%Search for SEC Filing on Google Icon
11/7/2025Vanguard Group Inc.15,547,508$42.45M0.0%+6.4%5.864%Search for SEC Filing on Google Icon
11/7/2025JPMorgan Chase & Co.994,181$2.71M0.0%-39.8%0.375%Search for SEC Filing on Google Icon
11/6/2025Rhumbline Advisers358,671$0.98M0.0%-1.7%0.135%Search for SEC Filing on Google Icon
11/6/2025Profund Advisors LLC103,974$0.28M0.0%+88.8%0.039%Search for SEC Filing on Google Icon
11/6/2025ProShare Advisors LLC42,750$0.12M0.0%-16.6%0.016%Search for SEC Filing on Google Icon
11/5/2025Alps Advisors Inc.126,061$0.34M0.0%-11.0%0.048%Search for SEC Filing on Google Icon
11/4/2025Principal Financial Group Inc.226,613$0.62M0.0%+1,237.0%0.085%Search for SEC Filing on Google Icon
11/3/2025Arizona State Retirement System77,463$0.21M0.0%N/A0.029%Search for SEC Filing on Google Icon
11/3/2025Federated Hermes Inc.639,372$1.75M0.0%+3.6%0.241%Search for SEC Filing on Google Icon
10/28/2025Wealth Effects LLC16,000$44K0.0%-53.6%0.006%Search for SEC Filing on Google Icon
10/27/2025Unified Investment Management18,000$49K0.0%N/A0.007%Search for SEC Filing on Google Icon
10/24/2025State of Alaska Department of Revenue15,625$42K0.0%N/A0.006%Search for SEC Filing on Google Icon
10/23/2025SG Americas Securities LLC116,393$0.32M0.0%N/A0.044%Search for SEC Filing on Google Icon
10/23/2025KLP Kapitalforvaltning AS54,800$0.15M0.0%N/A0.021%Search for SEC Filing on Google Icon
10/14/2025Parkwoods Wealth Partners LLC20,000$55K0.0%N/A0.008%Search for SEC Filing on Google Icon
10/9/2025Voya Investment Management LLC46,155$0.13M0.0%-33.1%0.017%Search for SEC Filing on Google Icon
10/7/2025Assenagon Asset Management S.A.426,766$1.17M0.0%N/A0.161%Search for SEC Filing on Google Icon
8/27/2025Squarepoint Ops LLC161,192$0.59M0.0%+257.9%0.061%Search for SEC Filing on Google Icon
8/15/2025Tower Research Capital LLC TRC 22,822$83K0.0%+263.0%0.009%Search for SEC Filing on Google Icon
8/15/2025E Fund Management Co. Ltd.28,273$0.10M0.0%+46.4%0.011%Search for SEC Filing on Google Icon
8/15/2025Rafferty Asset Management LLC253,954$0.92M0.0%+22.9%0.096%Search for SEC Filing on Google Icon
8/15/2025Man Group plc41,711$0.15M0.0%N/A0.016%Search for SEC Filing on Google Icon
8/15/2025Lazard Asset Management LLC116,485$0.42M0.0%N/A0.044%Search for SEC Filing on Google Icon
8/15/2025BNP Paribas Financial Markets520,629$1.90M0.0%+989.8%0.196%Search for SEC Filing on Google Icon
8/15/2025Brevan Howard Capital Management LP17,148$62K0.0%N/A0.006%Search for SEC Filing on Google Icon
8/15/2025Bank of America Corp DE1,110,480$4.04M0.0%+130.4%0.419%Search for SEC Filing on Google Icon
8/15/2025Ameriprise Financial Inc.176,948$0.64M0.0%+1,368.2%0.067%Search for SEC Filing on Google Icon
8/14/2025MPM Bioimpact LLC2,889,125$10.52M1.8%N/A1.090%Search for SEC Filing on Google Icon
8/14/2025Raymond James Financial Inc.59,502$0.22M0.0%+16.8%0.022%Search for SEC Filing on Google Icon
8/14/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.149,392$0.54M0.0%+8.3%0.056%Search for SEC Filing on Google Icon
8/14/2025The Manufacturers Life Insurance Company 89,677$0.33M0.0%+21.5%0.034%Search for SEC Filing on Google Icon
8/14/2025Sei Investments Co.191,245$0.70M0.0%+9.3%0.072%Search for SEC Filing on Google Icon
8/14/2025Qube Research & Technologies Ltd1,714,544$6.24M0.0%+60.5%0.647%Search for SEC Filing on Google Icon
8/14/2025Federated Hermes Inc.617,318$2.25M0.0%-32.4%0.233%Search for SEC Filing on Google Icon
8/13/2025Affinity Asset Advisors LLC1,950,000$7.10M1.0%+30.0%0.735%Search for SEC Filing on Google Icon
8/13/2025Diametric Capital LP57,532$0.21M0.1%-72.8%0.022%Search for SEC Filing on Google Icon
8/13/2025Walleye Capital LLC214,817$0.78M0.0%N/A0.081%Search for SEC Filing on Google Icon
8/13/2025Invesco Ltd.382,210$1.39M0.0%+46.7%0.144%Search for SEC Filing on Google Icon
8/13/2025OMERS ADMINISTRATION Corp123,700$0.45M0.0%N/A0.047%Search for SEC Filing on Google Icon
8/13/2025Panagora Asset Management Inc.210,205$0.77M0.0%N/A0.079%Search for SEC Filing on Google Icon
8/13/2025New York State Common Retirement Fund79,100$0.29M0.0%+106.0%0.030%Search for SEC Filing on Google Icon
8/13/2025Quadrature Capital Ltd81,944$0.30M0.0%+200.7%0.031%Search for SEC Filing on Google Icon
8/13/2025Russell Investments Group Ltd.98,823$0.36M0.0%-8.6%0.037%Search for SEC Filing on Google Icon
8/12/2025XTX Topco Ltd150,901$0.55M0.0%+228.0%0.057%Search for SEC Filing on Google Icon
8/12/2025Ameritas Investment Partners Inc.25,525$93K0.0%+25.2%0.010%Search for SEC Filing on Google Icon
8/12/2025Prudential Financial Inc.415,143$1.51M0.0%+542.2%0.157%Search for SEC Filing on Google Icon
8/12/2025American Century Companies Inc.89,937$0.33M0.0%N/A0.034%Search for SEC Filing on Google Icon
8/12/2025Rhumbline Advisers365,035$1.33M0.0%+29.4%0.138%Search for SEC Filing on Google Icon
8/12/2025Legal & General Group Plc23,279$85K0.0%+26.0%0.009%Search for SEC Filing on Google Icon
8/12/2025JPMorgan Chase & Co.1,652,746$6.02M0.0%+123.0%0.623%Search for SEC Filing on Google Icon
8/8/2025Intech Investment Management LLC142,928$0.52M0.0%+12.2%0.054%Search for SEC Filing on Google Icon
8/8/2025Creative Planning283,330$1.03M0.0%+23.4%0.108%Search for SEC Filing on Google Icon
8/8/2025Police & Firemen s Retirement System of New Jersey54,926$0.20M0.0%+31.3%0.021%Search for SEC Filing on Google Icon
8/8/2025Geode Capital Management LLC6,074,458$22.12M0.0%+20.7%2.313%Search for SEC Filing on Google Icon
8/7/2025ProShare Advisors LLC51,266$0.19M0.0%+9.4%0.020%Search for SEC Filing on Google Icon
8/7/2025Profund Advisors LLC55,062$0.20M0.0%+22.6%0.021%Search for SEC Filing on Google Icon
8/7/2025Acadian Asset Management LLC1,350,185$4.91M0.0%N/A0.514%Search for SEC Filing on Google Icon
8/7/2025Connor Clark & Lunn Investment Management Ltd.1,180,759$4.30M0.0%+21.7%0.450%Search for SEC Filing on Google Icon
8/6/2025Savant Capital LLC18,967$69K0.0%N/A0.007%Search for SEC Filing on Google Icon
8/1/2025Y Intercept Hong Kong Ltd30,657$0.11M0.0%N/A0.012%Search for SEC Filing on Google Icon
7/30/2025Ethic Inc.40,538$0.15M0.0%+243.8%0.015%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Akebia Therapeutics logo
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) in dialysis-dependent and non-dialysis dependent patients. It offers Auryxia, a ferric citrate that is used to control the serum phosphorus levels in adult patients with DD-CKD on dialysis; and the treatment of iron deficiency anemia in adult patients with CKD not on dialysis. The company's product pipeline includes AKB-9090, a drug targeting critical-care indications; and AKB-10108, a drug targeting conditions related to premature birth. It has collaboration agreements with Mitsubishi Tanabe Pharma Corporation for the development and commercialization of vadadustat in Japan and other Asian countries, as well as research and license agreement with Janssen Pharmaceutica NV for the development and commercialization of hypoxia-inducible factor prolyl hydroxylase targeted compounds worldwide. Akebia Therapeutics, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.
Read More on Akebia Therapeutics

Today's Range

Now: $1.59
Low: $1.53
High: $1.61

50 Day Range

MA: $2.29
Low: $1.47
High: $3.17

52 Week Range

Now: $1.59
Low: $1.45
High: $4.08

Volume

1,995,511 shs

Average Volume

4,952,545 shs

Market Capitalization

$421.94 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.31

Who are the company insiders with the largest holdings of Akebia Therapeutics?

Akebia Therapeutics' top insider shareholders include:
  1. John P Butler (CEO)
  2. Steven Keith Burke (SVP)
  3. Michel Dahan (COO)
  4. Nicole R Hadas (SVP)
  5. Erik Ostrowski (CFO)
  6. Nicholas Grund (Insider)
  7. Richard C Malabre (CAO)
Learn More about top insider investors at Akebia Therapeutics.

Who are the major institutional investors of Akebia Therapeutics?

Akebia Therapeutics' top institutional investors include:
  1. Vanguard Group Inc. — 5.86%
  2. UBS Group AG — 1.38%
  3. Qube Research & Technologies Ltd — 1.21%
  4. Millennium Management LLC — 1.08%
  5. Franklin Resources Inc. — 1.01%
  6. Invesco Ltd. — 0.91%
Learn More about top institutional investors of Akebia Therapeutics stock.

Which institutional investors are selling Akebia Therapeutics stock?

Within the last quarter, AKBA stock was sold by these institutional investors:
  1. JPMorgan Chase & Co.
  2. Jacobs Levy Equity Management Inc.
  3. Ameriprise Financial Inc.
  4. Sei Investments Co.
  5. Lazard Asset Management LLC
  6. Group One Trading LLC
  7. Intech Investment Management LLC
  8. Susquehanna International Group LLP
Within the last year, company insiders that have sold Akebia Therapeutics company stock include:
  1. John P Butler (CEO)
  2. Steven Keith Burke (SVP)
  3. Michel Dahan (COO)
  4. Nicole R Hadas (SVP)
  5. Erik Ostrowski (CFO)
Learn More investors selling Akebia Therapeutics stock.

Which institutional investors are buying Akebia Therapeutics stock?

Within the previous quarter, AKBA stock was acquired by institutional investors including:
  1. UBS Group AG
  2. Invesco Ltd.
  3. Citigroup Inc.
  4. Qube Research & Technologies Ltd
  5. Vanguard Group Inc.
  6. Dimensional Fund Advisors LP
  7. Millennium Management LLC
  8. Bank of America Corp DE